Introduction The surgical treatment known as brachioplasty, or "arm lift," is used to remodel the back of the upper arm by cutting away extra fat and remaining tissues to enhance the look. Due to several variables, including an increase in weight loss surgeries, an increase in the value of self-esteem, improvements in surgical and non-surgical treatments, an increase in the geriatric population, and rising obesity rates, the market is predicted to expand. According to the State of Obesity 2022 report, obesity affects four out of ten Americans, and rates are increasing both nationally and across other population groups.
Growth in the market will also be fueled by the expanding link between self-esteem and attractiveness. In industrialized nations, the senior population is becoming more prevalent, which benefits market expansion. Furthermore, the American Academy of Dermatology Association reported that there were no serious side effects seen in elderly patients undergoing cosmetic procedures. Due to a better lifestyle, older patients who underwent body-contouring surgeries like brachioplasty had superior operative outcomes.
More than 56 million Americans will be over the age of 65 in 2021, based on the American Health Ranking. The aging population's increasing need for cosmetic operations, which boosts self-esteem and quality of life by improving appearance, is what's driving the market's growth. Another element driving demand is the treatment's cheaper cost compared to surgical procedures. According to the Plastic Surgery Statistics Report 2020 from the American Society for Plastic Surgeons, 15.6 million cosmetic surgery treatments were performed in the US in 2020. In addition, the region has strong access to cosmetic surgery services, high levels of awareness and technological innovation, and a wide spectrum of disposable money, all of which contribute to high demand.
The US market dominated the North America Brachioplasty Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $602.7 million by 2030. The Canada market is showcasing a CAGR of 9.3% during (2023-2030). Additionally, The Mexico market would register a CAGR of 8.4% during (2023-2030).
Based on Procedure, the market is segmented into Surgical and Non-Surgical. Based on End-use, the market is segmented into Cosmetic Surgery Clinics and Hospitals. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include New York Group for Plastic Surgery, Westlake Dermatology & Cosmetic Surgery, Ruby Plastic Surgery, Cadogan Clinic, UK Aesthetic, Centre for Surgery, Marroquin & Sandoval Plastic Surgery, Nazarian Plastic Surgery, B. Care Hospital.
Scope of the Study
By Procedure
- Surgical
- Non-Surgical
By End-use
- Cosmetic Surgery Clinics
- Hospitals
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- New York Group for Plastic Surgery
- Westlake Dermatology & Cosmetic Surgery
- Ruby Plastic Surgery
- Cadogan Clinic
- UK Aesthetic
- Centre for Surgery
- Marroquin & Sandoval Plastic Surgery
- Nazarian Plastic Surgery
- B.Care Hospital
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- New York Group for Plastic Surgery
- Westlake Dermatology & Cosmetic Surgery
- Ruby Plastic Surgery
- Cadogan Clinic
- UK Aesthetic
- Centre for Surgery
- Marroquin & Sandoval Plastic Surgery
- Nazarian Plastic Surgery
- B. Care Hospital
Methodology
LOADING...